Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline von van Os, N.J.H., Roeleveld, N., Weemaes, C.M.R., Jongmans, M.C.J., Janssens, G.O., Taylor, A.M.R., Hoogerbrugge, N., Willemsen, M.A.A.P.

Volltext

Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression von Cleophas, M C P, Crişan, T O, Klück, V, Hoogerbrugge, N, Netea-Maier, R T, Dinarello, C A, Netea, M G, Joosten, L A B

Volltext

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers von van der Post, R S, Kiemeney, L A, Ligtenberg, M J L, Witjes, J A, Hulsbergen-van de Kaa, C A, Bodmer, D, Schaap, L, Kets, C M, van Krieken, J H J M, Hoogerbrugge, N

Volltext

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome von Tischkowitz, Marc, Colas, Chrystelle, Pouwels, Sjaak, Hoogerbrugge, Nicoline

Volltext

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer von Koopman, M, Kortman, G A M, Mekenkamp, L, Ligtenberg, M J L, Hoogerbrugge, N, Antonini, N F, Punt, C J A, van Krieken, J H J M

Volltext

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing von Rowlands, C.F., Allen, S., Balmaña, J., Domchek, S.M., Evans, D.G., Hanson, H., Hoogerbrugge, N., James, P.A., Nathanson, K.L., Robson, M., Tischkowitz, M., Foulkes, W.D., Turnbull, C.

Volltext

Breast cancer surveillance in women with PTEN Hamartoma Tumour Syndrome (PHTS) von Hoxhaj, A., Drissen, M., Vos, J., Mann, R.M., Hoogerbrugge, N.

Volltext

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences von Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

Volltext

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience von Harmsen, M.G, Arts-de Jong, M, Horstik, K, Manders, P, Massuger, L.F.A.G, Hermens, R.P.M.G, Hoogerbrugge, N, Woldringh, G.H, de Hullu, J.A

Volltext

Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients von Hoedjes, M, Vrieling, A, de Brauwer, L, Visser, A, Gómez García, E, Hoogerbrugge, N, Kampman, E

Volltext

Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition von Diets, I J, Nagtegaal, I D, Loeffen, J, de Blaauw, I, Waanders, E, Hoogerbrugge, N, Jongmans, M C J

Volltext

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome von Jongmans, M C J, Kuiper, R P, Carmichael, C L, Wilkins, E J, Dors, N, Carmagnac, A, Schouten-van Meeteren, A Y N, Li, X, Stankovic, M, Kamping, E, Bengtsson, H, Schoenmakers, E F P M, van Kessel, A Geurts, Hoogerbrugge, P M, Hahn, C N, Brons, P P, Scott, H S, Hoogerbrugge, N

Volltext

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer von Park, D.J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S.L., John, E.M., Andrulis, I.L., Terry, M.B., Daly, M., Buys, S., Le Calvez-Kelm, F., Lonie, A., Pope, B.J., Tsimiklis, H., Voegele, C., Hilbers, F.M., Hoogerbrugge, N., Barroso, A., Osorio, A., Giles, G.G., Devilee, P., Benitez, J., Hopper, J.L., Tavtigian, S.V., Goldgar, D.E., Southey, M.C.

Volltext

Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research von Burbach, J P M, Kurk, S A, Coebergh van den Braak, R R J, Dik, V K, May, A M, Meijer, G A, Punt, C J A, Vink, G R, Los, M, Hoogerbrugge, N, Huijgens, P C, Ijzermans, J N M, Kuipers, E J, de Noo, M E, Pennings, J P, van der Velden, A M T, Verhoef, C, Siersema, P D, van Oijen, M G H, Verkooijen, H M, Koopman, M

Volltext

TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes von Ruijs, Marielle W G, Verhoef, Senno, Rookus, Matti A, Pruntel, Roelof, van der Hout, Annemarie H, Hogervorst, Frans B L, Kluijt, I, Sijmons, Rolf H, Aalfs, Cora M, Wagner, Anja, Ausems, Margreet G E M, Hoogerbrugge, Nicoline, van Asperen, Christi J, Gomez Garcia, Encarna B, Meijers-Heijboer, Hanne, ten Kate, Leo P, Menko, Fred H, van 't Veer, Laura J

Volltext

HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma von van der Post, R. S., Bult, P., Vogelaar, I. P., Ligtenberg, M. J. L., Hoogerbrugge, N., van Krieken, J. H.

Volltext

Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial von Vrieling, A., Visser, A., Hoedjes, M., Hurks, M., Gómez García, E., Hoogerbrugge, N., Kampman, E.

Volltext

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI von Veltman, J., Mann, R., Kok, T., Obdeijn, I. M., Hoogerbrugge, N., Blickman, J. G., Boetes, C.

Volltext

Cardiovascular risk of BRCA1/2 mutation carriers: a review von van Westerop, L.L.M, Arts-de Jong, M, Hoogerbrugge, N, de Hullu, J.A, Maas, A.H.E.M

Volltext

Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective von Sie, A.S., Mensenkamp, A.R., Adang, E.M.M., Ligtenberg, M.J.L., Hoogerbrugge, N.

Volltext